These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 16652059)
1. Transitions to injecting drug use among noninjecting heroin users: social network influence and individual susceptibility. Neaigus A; Gyarmathy VA; Miller M; Frajzyngier VM; Friedman SR; Des Jarlais DC J Acquir Immune Defic Syndr; 2006 Apr; 41(4):493-503. PubMed ID: 16652059 [TBL] [Abstract][Full Text] [Related]
2. Potential risk factors for the transition to injecting among non-injecting heroin users: a comparison of former injectors and never injectors. Neaigus A; Miller M; Friedman SR; Hagen DL; Sifaneck SJ; Ildefonso G; des Jarlais DC Addiction; 2001 Jun; 96(6):847-60. PubMed ID: 11399216 [TBL] [Abstract][Full Text] [Related]
3. High rates of transitions to injecting drug use among Mexican American non-injecting heroin users in San Antonio, Texas (never and former injectors). Valdez A; Neaigus A; Kaplan C; Cepeda A Drug Alcohol Depend; 2011 Apr; 114(2-3):233-6. PubMed ID: 21075561 [TBL] [Abstract][Full Text] [Related]
4. The transition from injection to non-injection drug use: long-term outcomes among heroin and cocaine users in New York City. Des Jarlais DC; Arasteh K; Perlis T; Hagan H; Heckathorn DD; Mcknight C; Bramson H; Friedman SR Addiction; 2007 May; 102(5):778-85. PubMed ID: 17506155 [TBL] [Abstract][Full Text] [Related]
5. Sexual and other noninjection risks for HBV and HCV seroconversions among noninjecting heroin users. Neaigus A; Gyarmathy VA; Zhao M; Miller M; Friedman SR; Des Jarlais DC J Infect Dis; 2007 Apr; 195(7):1052-61. PubMed ID: 17330797 [TBL] [Abstract][Full Text] [Related]
6. From Long-Term Injecting to Long-Term Non-Injecting Heroin and Cocaine Use: The Persistence of Changed Drug Habits. Jarlais DC; Arasteh K; Feelemyer J; McKnight C; Barnes DM; Tross S; Perlman DC; Campbell AN; Cooper HL; Hagan H J Subst Abuse Treat; 2016 Dec; 71():48-53. PubMed ID: 27776677 [TBL] [Abstract][Full Text] [Related]
7. HCV seroconversion among never-injecting heroin users at baseline: no predictors identified other than starting injection. Bravo MJ; Vallejo F; Barrio G; Brugal MT; Molist G; Pulido J; Sordo L; de la Fuente L; Int J Drug Policy; 2012 Sep; 23(5):415-9. PubMed ID: 22421554 [TBL] [Abstract][Full Text] [Related]
8. Risk correlates of prevalent HIV, hepatitis B virus, and hepatitis C virus infections among noninjecting heroin users. Gyarmathy VA; Neaigus A; Miller M; Friedman SR; Des Jarlais DC J Acquir Immune Defic Syndr; 2002 Aug; 30(4):448-56. PubMed ID: 12138352 [TBL] [Abstract][Full Text] [Related]
9. "Every 'never' I ever said came true": transitions from opioid pills to heroin injecting. Mars SG; Bourgois P; Karandinos G; Montero F; Ciccarone D Int J Drug Policy; 2014 Mar; 25(2):257-66. PubMed ID: 24238956 [TBL] [Abstract][Full Text] [Related]
10. Potential risk factors for injecting among Mexican American non-injecting heroin users. Valdez A; Neaigus A; Cepeda A J Ethn Subst Abuse; 2007; 6(2):49-73. PubMed ID: 18192204 [TBL] [Abstract][Full Text] [Related]
11. Heroin transition risk among daily and non-daily cannabis users who are non-injectors of heroin. Valdez A; Cepeda A; Neaigus A; Russell A Int J Drug Policy; 2008 Dec; 19(6):442-9. PubMed ID: 19038723 [TBL] [Abstract][Full Text] [Related]
12. Injecting transition risk and depression among Mexican American non-injecting heroin users. Cepeda A; Kaplan C; Neaigus A; Cano MÁ; Villarreal Y; Valdez A Drug Alcohol Depend; 2012 Sep; 125 Suppl 1(0 1):S12-7. PubMed ID: 22749681 [TBL] [Abstract][Full Text] [Related]
13. Patterns of substance use and mortality risk in a cohort of 'hard-to-reach' polysubstance users. Gjersing L; Bretteville-Jensen AL Addiction; 2018 Apr; 113(4):729-739. PubMed ID: 28987019 [TBL] [Abstract][Full Text] [Related]
14. Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City. Des Jarlais DC; Arasteh K; Perlis T; Hagan H; Abdul-Quader A; Heckathorn DD; McKnight C; Bramson H; Nemeth C; Torian LV; Friedman SR AIDS; 2007 Jan; 21(2):231-5. PubMed ID: 17197815 [TBL] [Abstract][Full Text] [Related]
15. Characterizing the drug-injecting networks of cocaine and heroin injectors in Montreal. De P; Jolly A; Cox J; Boivin JF Can J Public Health; 2006; 97(3):207-9. PubMed ID: 16827407 [TBL] [Abstract][Full Text] [Related]
16. Sexual transmission risk among noninjecting heroin users infected with human immunodeficiency virus or hepatitis C virus. Neaigus A; Miller M; Friedman SR; Des Jarlais DC J Infect Dis; 2001 Aug; 184(3):359-63. PubMed ID: 11443564 [TBL] [Abstract][Full Text] [Related]
17. High Prevalence and Incidence of HIV and HCV Among New Injecting Drug Users With a Large Proportion of Migrants--Is Prevention Failing? Folch C; Casabona J; Espelt A; Majó X; Meroño M; Gonzalez V; Wiessing L; Colom J; Brugal MT; Subst Use Misuse; 2016 Jan; 51(2):250-60. PubMed ID: 26820260 [TBL] [Abstract][Full Text] [Related]
18. Cessation of injecting drug use among street-based youth. Steensma C; Boivin JF; Blais L; Roy E J Urban Health; 2005 Dec; 82(4):622-37. PubMed ID: 16195471 [TBL] [Abstract][Full Text] [Related]
19. Heroin chasers and heroin injectors: differences observed in a community sample in London, UK. Strang J; Griffiths P; Powis B; Gossop M Am J Addict; 1999; 8(2):148-60. PubMed ID: 10365195 [TBL] [Abstract][Full Text] [Related]
20. Transitions between the injection of heroin and amphetamines. Darke S; Kaye S; Ross J Addiction; 1999 Dec; 94(12):1795-803. PubMed ID: 10717958 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]